Lauren M Huyett1,2, Trang T Ly3, Gregory P Forlenza4, Suzette Reuschel-DiVirgilio3, Laurel H Messer4, R Paul Wadwa4, Ravi Gondhalekar2,5, Francis J Doyle1,2,5, Jordan E Pinsker2, David M Maahs3,4, Bruce A Buckingham3, Eyal Dassau1,2,5. 1. 1 Department of Chemical Engineering, University of California Santa Barbara , Santa Barbara, California. 2. 2 William Sansum Diabetes Center , Santa Barbara, California. 3. 3 Department of Pediatrics, Division of Pediatric Endocrinology and Diabetes, Stanford University , Stanford, California. 4. 4 Barbara Davis Center for Childhood Diabetes, University of Colorado Anschutz Medical Campus , Aurora, Colorado. 5. 5 Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University , Cambridge, Massachusetts.
Abstract
BACKGROUND: The artificial pancreas (AP) has the potential to improve glycemic control in adolescents. This article presents the first evaluation in adolescents of the Zone Model Predictive Control and Health Monitoring System (ZMPC+HMS) AP algorithms, and their first evaluation in a supervised outpatient setting with frequent exercise. MATERIALS AND METHODS: Adolescents with type 1 diabetes underwent 3 days of closed-loop control (CLC) in a hotel setting with the ZMPC+HMS algorithms on the Diabetes Assistant platform. Subjects engaged in twice-daily exercise, including soccer, tennis, and bicycling. Meal size (unrestricted) was estimated and entered into the system by subjects to trigger a bolus, but exercise was not announced. RESULTS: Ten adolescents (11.9-17.7 years) completed 72 h of CLC, with data on 95 ± 14 h of sensor-augmented pump (SAP) therapy before CLC as a comparison to usual therapy. The percentage of time with continuous glucose monitor (CGM) 70-180 mg/dL was 71% ± 10% during CLC, compared to 57% ± 16% during SAP (P = 0.012). Nocturnal control during CLC was safe, with 0% (0%, 0.6%) of time with CGM <70 mg/dL compared to 1.1% (0.0%, 14%) during SAP. Despite large meals (estimated up to 120 g carbohydrate), only 8.0% ± 6.9% of time during CLC was spent with CGM >250 mg/dL (16% ± 14% during SAP). The system remained connected in CLC for 97% ± 2% of the total study time. No adverse events or severe hypoglycemia occurred. CONCLUSIONS: The use of the ZMPC+HMS algorithms is feasible in the adolescent outpatient environment and achieved significantly more time in the desired glycemic range than SAP in the face of unannounced exercise and large announced meal challenges.
BACKGROUND: The artificial pancreas (AP) has the potential to improve glycemic control in adolescents. This article presents the first evaluation in adolescents of the Zone Model Predictive Control and Health Monitoring System (ZMPC+HMS) AP algorithms, and their first evaluation in a supervised outpatient setting with frequent exercise. MATERIALS AND METHODS: Adolescents with type 1 diabetes underwent 3 days of closed-loop control (CLC) in a hotel setting with the ZMPC+HMS algorithms on the Diabetes Assistant platform. Subjects engaged in twice-daily exercise, including soccer, tennis, and bicycling. Meal size (unrestricted) was estimated and entered into the system by subjects to trigger a bolus, but exercise was not announced. RESULTS: Ten adolescents (11.9-17.7 years) completed 72 h of CLC, with data on 95 ± 14 h of sensor-augmented pump (SAP) therapy before CLC as a comparison to usual therapy. The percentage of time with continuous glucose monitor (CGM) 70-180 mg/dL was 71% ± 10% during CLC, compared to 57% ± 16% during SAP (P = 0.012). Nocturnal control during CLC was safe, with 0% (0%, 0.6%) of time with CGM <70 mg/dL compared to 1.1% (0.0%, 14%) during SAP. Despite large meals (estimated up to 120 g carbohydrate), only 8.0% ± 6.9% of time during CLC was spent with CGM >250 mg/dL (16% ± 14% during SAP). The system remained connected in CLC for 97% ± 2% of the total study time. No adverse events or severe hypoglycemia occurred. CONCLUSIONS: The use of the ZMPC+HMS algorithms is feasible in the adolescent outpatient environment and achieved significantly more time in the desired glycemic range than SAP in the face of unannounced exercise and large announced meal challenges.
Entities:
Keywords:
Adolescent; Algorithms; Artificial pancreas; Exercise; Type 1 diabetes
Authors: Trang T Ly; Anirban Roy; Benyamin Grosman; John Shin; Alex Campbell; Salman Monirabbasi; Bradley Liang; Rie von Eyben; Satya Shanmugham; Paula Clinton; Bruce A Buckingham Journal: Diabetes Care Date: 2015-06-06 Impact factor: 19.112
Authors: Kellee M Miller; Nicole C Foster; Roy W Beck; Richard M Bergenstal; Stephanie N DuBose; Linda A DiMeglio; David M Maahs; William V Tamborlane Journal: Diabetes Care Date: 2015-06 Impact factor: 19.112
Authors: Kenneth Robertson; Michael C Riddell; Benjamin C Guinhouya; Peter Adolfsson; Ragnar Hanas Journal: Pediatr Diabetes Date: 2014-09 Impact factor: 4.866
Authors: Rebecca A Harvey; Eyal Dassau; Wendy C Bevier; Dale E Seborg; Lois Jovanovič; Francis J Doyle; Howard C Zisser Journal: Diabetes Technol Ther Date: 2014-01-28 Impact factor: 6.118
Authors: Ayse Pinar Cemeroglu; Jason P Thomas; Luke T Vande Zande; Nga T Nguyen; Michael A Wood; Lora Kleis; Alan T Davis Journal: Endocr Pract Date: 2013 Sep-Oct Impact factor: 3.443
Authors: Stuart A Weinzimer; Garry M Steil; Karena L Swan; Jim Dziura; Natalie Kurtz; William V Tamborlane Journal: Diabetes Care Date: 2008-02-05 Impact factor: 19.112
Authors: Trang T Ly; Bruce A Buckingham; Daniel J DeSalvo; Satya Shanmugham; Marta Satin-Smith; Mark D DeBoer; Mary C Oliveri; Elaine Schertz; Marc D Breton; Daniel R Cherñavvsky Journal: Diabetes Care Date: 2016-06-06 Impact factor: 19.112
Authors: D Elleri; M Biagioni; J M Allen; K Kumareswaran; L Leelarathna; K Caldwell; M Nodale; M E Wilinska; A Haidar; P Calhoun; C Kollman; N C Jackson; A M Umpleby; C L Acerini; D B Dunger; R Hovorka Journal: Diabetes Obes Metab Date: 2015-10-09 Impact factor: 6.577
Authors: Gregory P Forlenza; Faye M Cameron; Trang T Ly; David Lam; Daniel P Howsmon; Nihat Baysal; Georgia Kulina; Laurel Messer; Paula Clinton; Camilla Levister; Stephen D Patek; Carol J Levy; R Paul Wadwa; David M Maahs; B Wayne Bequette; Bruce A Buckingham Journal: Diabetes Technol Ther Date: 2018-04-16 Impact factor: 6.118
Authors: Gregory P Forlenza; Sunil Deshpande; Trang T Ly; Daniel P Howsmon; Faye Cameron; Nihat Baysal; Eric Mauritzen; Tatiana Marcal; Lindsey Towers; B Wayne Bequette; Lauren M Huyett; Jordan E Pinsker; Ravi Gondhalekar; Francis J Doyle; David M Maahs; Bruce A Buckingham; Eyal Dassau Journal: Diabetes Care Date: 2017-06-05 Impact factor: 19.112
Authors: Daniel P Howsmon; Nihat Baysal; Bruce A Buckingham; Gregory P Forlenza; Trang T Ly; David M Maahs; Tatiana Marcal; Lindsey Towers; Eric Mauritzen; Sunil Deshpande; Lauren M Huyett; Jordan E Pinsker; Ravi Gondhalekar; Francis J Doyle; Eyal Dassau; Juergen Hahn; B Wayne Bequette Journal: J Diabetes Sci Technol Date: 2018-02-01